163 related articles for article (PubMed ID: 35395098)
1. Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia.
Alonso-Peña M; Espinosa-Escudero R; Herraez E; Briz O; Cagigal ML; Gonzalez-Santiago JM; Ortega-Alonso A; Fernandez-Rodriguez C; Bujanda L; Calvo Sanchez M; D Avola D; Londoño MC; Diago M; Fernandez-Checa JC; Garcia-Ruiz C; Andrade RJ; Lammert F; Prieto J; Crespo J; Juamperez J; Diaz-Gonzalez A; Monte MJ; Marin JJG
Hepatology; 2022 Nov; 76(5):1259-1274. PubMed ID: 35395098
[TBL] [Abstract][Full Text] [Related]
2. ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia.
Monte MJ; Alonso-Peña M; Briz O; Herraez E; Berasain C; Argemi J; Prieto J; Marin JJG
J Hepatol; 2017 Mar; 66(3):581-588. PubMed ID: 27884763
[TBL] [Abstract][Full Text] [Related]
3. A novel case of ACOX2 deficiency leads to recognition of a third human peroxisomal acyl-CoA oxidase.
Ferdinandusse S; Denis S; van Roermund CWT; Preece MA; Koster J; Ebberink MS; Waterham HR; Wanders RJA
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):952-958. PubMed ID: 29287774
[TBL] [Abstract][Full Text] [Related]
4. ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.
Vilarinho S; Sari S; Mazzacuva F; Bilgüvar K; Esendagli-Yilmaz G; Jain D; Akyol G; Dalgiç B; Günel M; Clayton PT; Lifton RP
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11289-11293. PubMed ID: 27647924
[TBL] [Abstract][Full Text] [Related]
5. Sensitive analysis of serum 3alpha, 7alpha, 12alpha,24-tetrahydroxy- 5beta-cholestan-26-oic acid diastereomers using gas chromatography-mass spectrometry and its application in peroxisomal D-bifunctional protein deficiency.
Vreken P; van Rooij A; Denis S; van Grunsven EG; Cuebas DA; Wanders RJ
J Lipid Res; 1998 Dec; 39(12):2452-8. PubMed ID: 9831634
[TBL] [Abstract][Full Text] [Related]
6. Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation.
Alonso-Peña M; Espinosa-Escudero R; Hermanns HM; Briz O; Herranz JM; Garcia-Ruiz C; Fernandez-Checa JC; Juamperez J; Avila M; Argemi J; Bataller R; Crespo J; Monte MJ; Geier A; Herraez E; Marin JJG
Cells; 2022 Dec; 11(24):. PubMed ID: 36552746
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of ACOX2 in non-small cell lung cancer.
Sui JSY; Martin P; Keogh A; Murchan P; Ryan L; Nicholson S; Cuffe S; Broin PÓ; Finn SP; Fitzmaurice GJ; Ryan R; Young V; Gray SG
BMC Pulm Med; 2022 Aug; 22(1):321. PubMed ID: 35999530
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and expression of cDNA encoding 3alpha,7alpha,12alpha-trihydroxy-5beta-chole stanoyl-CoA oxidase from rabbit liver.
Pedersen JI; Eggertsen G; Hellman U; Andersson U; Björkhem I
J Biol Chem; 1997 Jul; 272(29):18481-9. PubMed ID: 9218493
[TBL] [Abstract][Full Text] [Related]
9. Study on stereospecificity of enzyme reaction related to peroxisomal bile acid synthesis in rat liver.
Koibuchi Y; Yamada J; Watanabe T; Kurosawa T; Tohma M; Suga T
Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):446-8. PubMed ID: 1351423
[TBL] [Abstract][Full Text] [Related]
10. Human hepatoblastoma cells (HepG2) and rat hepatoma cells are defective in important enzyme activities in the oxidation of the C27 steroid side chain in bile acid formation.
Farrants AK; Nilsson A; Pedersen JI
J Lipid Res; 1993 Dec; 34(12):2041-50. PubMed ID: 8301225
[TBL] [Abstract][Full Text] [Related]
11. Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.
Bjørklund SS; Kristensen VN; Seiler M; Kumar S; Alnæs GI; Ming Y; Kerrigan J; Naume B; Sachidanandam R; Bhanot G; Børresen-Dale AL; Ganesan S
BMC Cancer; 2015 Jul; 15():524. PubMed ID: 26183823
[TBL] [Abstract][Full Text] [Related]
12. Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling.
Mihalik SJ; Steinberg SJ; Pei Z; Park J; Kim DG; Heinzer AK; Dacremont G; Wanders RJ; Cuebas DA; Smith KD; Watkins PA
J Biol Chem; 2002 Jul; 277(27):24771-9. PubMed ID: 11980911
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
14. Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition.
Ueda H; Honda A; Miyazaki T; Morishita Y; Hirayama T; Iwamoto J; Nakamoto N; Ikegami T
PLoS One; 2022; 17(7):e0271308. PubMed ID: 35819971
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid oxidation and of bile acid secretion in rat liver by fatty acids.
Casteels M; Schepers L; Van Eldere J; Eyssen HJ; Mannaerts GP
J Biol Chem; 1988 Apr; 263(10):4654-61. PubMed ID: 3350807
[TBL] [Abstract][Full Text] [Related]
16. Effect of the side-chain structure on the specificity of beta-oxidation in bile acid biosynthesis in rat liver homogenates.
Kurosawa T; Sato M; Watanabe T; Suga T; Tohma M
J Lipid Res; 1997 Dec; 38(12):2589-602. PubMed ID: 9458282
[TBL] [Abstract][Full Text] [Related]
17. Development of a system adapted for the diagnosis and evaluation of peroxisomal disorders by measuring bile acid intermediates.
Kawai H; Takashima S; Ohba A; Toyoshi K; Kubota K; Ohnishi H; Shimozawa N
Brain Dev; 2023 Jan; 45(1):58-69. PubMed ID: 36511274
[TBL] [Abstract][Full Text] [Related]
18. The catabolism of cholesterol in vitro. Formation of 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoic acid from cholesterol by rat liver.
Mendelsohn D; Mendelsohn L
Biochem J; 1969 Aug; 114(1):1-3. PubMed ID: 5810058
[TBL] [Abstract][Full Text] [Related]
19. The role of alpha-methylacyl-CoA racemase in bile acid synthesis.
Cuebas DA; Phillips C; Schmitz W; Conzelmann E; Novikov DK
Biochem J; 2002 May; 363(Pt 3):801-7. PubMed ID: 11964182
[TBL] [Abstract][Full Text] [Related]
20. Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats.
Slopianka M; Herrmann A; Pavkovic M; Ellinger-Ziegelbauer H; Ernst R; Mally A; Keck M; Riefke B
Toxicology; 2017 Jul; 386():1-10. PubMed ID: 28529062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
